Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:1398-1406
doi: 10.1161/01.CIR.0000158482.83179.DB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeda, R.
Right arrow Articles by Hirata, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeda, R.
Right arrow Articles by Hirata, Y.
Related Collections
Right arrow Obesity
Right arrow Restenosis
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Gene therapy
Right arrow Mechanism of atherosclerosis/growth factors

(Circulation. 2005;111:1398-1406.)
© 2005 American Heart Association, Inc.


Molecular Cardiology

Blockade of Endogenous Cytokines Mitigates Neointimal Formation in Obese Zucker Rats

Ryo Takeda, MD; Etsu Suzuki, MD; Hiroshi Satonaka, MD; Shigeyoshi Oba, MD; Hiroaki Nishimatsu, MD; Masao Omata, MD; Toshiro Fujita, MD; Ryozo Nagai, MD; Yasunobu Hirata, MD

From the Departments of Internal Medicine (R.T., E.S., H.S., S.O., M.O., T.F., R.N., Y.H.) and Urology (H.N.), Faculty of Medicine, University of Tokyo, Tokyo, Japan.

Correspondence to Etsu Suzuki, MD, Division of Nephrology and Endocrinology No. 202, Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail suzuki-2im{at}h.u-tokyo.ac.jp

Received June 14, 2004; revision received November 6, 2004; accepted November 17, 2004.

Background— It is well known that diabetes mellitus is a major risk factor for vascular diseases such as atherosclerosis and restenosis after angioplasty. It has become clear that advanced glycation end products (AGE) and their receptor (RAGE) are implicated in vascular diseases, especially in diabetes mellitus. Nevertheless, the mechanisms by which diabetes mellitus is often associated with vascular diseases remain unclear.

Methods and Results— To study the role of endogenous cytokines such as tumor necrosis factor-{alpha} (TNF-{alpha}) and interleukin-6 in the development of vascular diseases and in the expression of RAGE, we used semapimod, a pharmacological inhibitor of cytokine production, and examined its effect on neointimal formation in the femoral artery of obese Zucker (OZ) rats. We also used an adenovirus construct expressing a dominant negative mutant of the receptor for TNF-{alpha} (AdTNFR{Delta}C) to block the action of endogenous TNF-{alpha}. Semapimod significantly suppressed neointimal formation and RAGE expression in OZ rats compared with untreated OZ rats. This inhibitory effect of semapimod on neointimal formation was overcome by infection of an adenovirus expressing RAGE into the femoral artery of OZ rats. Furthermore, AdTNFR{Delta}C infection significantly suppressed neointimal formation and RAGE expression in the femoral artery of OZ rats.

Conclusions— These results suggest that endogenous cytokines, especially TNF-{alpha}, were implicated in neointimal formation in OZ rats and that RAGE was a mediator of the effect of these cytokines on neointimal formation.


Key Words: diabetes mellitus • angioplasty • gene therapy




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Takahashi, E. Suzuki, R. Takeda, S. Oba, H. Nishimatsu, K. Kimura, T. Nagano, R. Nagai, and Y. Hirata
Angiotensin II and tumor necrosis factor-{alpha} synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-{kappa}B, p38, and reactive oxygen species
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2879 - H2888.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Caglayan and S. Rosenkranz
Living on the Edge: Hypoxia-Induced Tissue Damage
Circ. Res., April 25, 2008; 102(8): 864 - 865.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Rajesh, P. Mukhopadhyay, S. Batkai, G. Hasko, L. Liaudet, J. W. Huffman, A. Csiszar, Z. Ungvari, K. Mackie, S. Chatterjee, et al.
CB2-receptor stimulation attenuates TNF-{alpha}-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2210 - H2218.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. V. Ramana, R. Tammali, A. B. M. Reddy, A. Bhatnagar, and S. K. Srivastava
Aldose Reductase-Regulated Tumor Necrosis Factor-{alpha} Production Is Essential for High Glucose-Induced Vascular Smooth Muscle Cell Growth
Endocrinology, September 1, 2007; 148(9): 4371 - 4384.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Batkai, M. Rajesh, P. Mukhopadhyay, G. Hasko, L. Liaudet, B. F. Cravatt, A. Csiszar, Z. Ungvari, and P. Pacher
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H909 - H918.
[Abstract] [Full Text] [PDF]